RMD News and Press, ResMed Inc. From 08/04/23

2023-08-04 10:09:12 ET Gainers: Alector ( ALEC ) +22% . OraSure Technologies ( OSUR ) +21% . Amneal Pharmaceuticals ( AMRX ) +20% . iRhythm Technologies ( IRTC ) +20% . Natera ( NTRA ) +16% . Losers: Mesoblast ( MESO ) ...

2023-08-03 21:13:07 ET ResMed, Inc. (RMD) Q4 2023 Earnings Conference Call August 3, 2023, 4:30 pm ET Company Participants Amy Wakeham - Chief Communications & IRO Mick Farrell - CEO Brett Sandercock - CFO Rob Douglas - President & COO Lucile Blai...

2023-08-03 16:39:25 ET ResMed press release ( NYSE: RMD ): Q4 Non-GAAP EPS of $1.60 misses by $0.09 . Revenue of $1.12B (+22.4% Y/Y) misses by $20M . Operating cash flow of $237.4 million. Gross margin contracted 210 bps to 55.0%; non-GAAP gross m...

Year-over-year revenue grows 23% , operating profit up 8% , non-GAAP operating profit up 13% Quarterly dividend increases 9% to $0.48 per share Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at htt...

2023-08-01 14:05:34 ET More on ResMed Compound Your Wealth With ResMed ResMed: Wait And See How The Return Of Key Competitor Will Impact ResMed ResMed raised to Buy at BofA citing Q1 beat ResMed downgraded at JPMorgan and RBC despite earnings beat See...

2023-07-25 11:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-07-24 15:07:25 ET Philips ( NYSE: PHG ) ADRs slipped ~6% on Monday, marking the second biggest intraday decline for the year after the company indicated a decrease in comparable order intake despite raising its full-year outlook with its Q2 2023 results. The Dutch m...

SAN DIEGO, July 06, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2023 on Thursday, August 3, 2023, after the New York Stock Exchange closes. Following the release, ResMed managemen...

2023-07-05 16:30:30 ET ResMed ( NYSE: RMD ) has bought Somnoware for an undisclosed sum, the company said Wednesday. Somnoware is a privately held company that provides software for sleep and respiratory care diagnostics. The company said it intends to retain a...

Expands ResMed’s sleep management software solution, will help sleep labs and physicians more efficiently guide patients into and through diagnosis to long-term treatment Diagnostic management platform is upstream of and complementary to ResMed’s current post-testing AirView...